Apologies for the extended dribble, I'll put it down to the half empty bottle of Macallan 12.
Just thinking, there seems to have been noticable shift in action/thinking in recent weeks. With a base now holding circa $0.30 and so many positives, I'm.keen to get the alternate/pessimist/realists perspective. Other than data, what could go wrong..
Positives:
*300/500% sustained volume increase
* SP responding and holding to positive announcements (very unlike IMM)
* Shorts essentially dissapeared
* Patents up the wazoo.. combo options per AJs posts
* large scale up for production, hard to see how this can be misinterpreted as anything other than confidence
* expansion of staffing, granted minor, but if you're expecting a downturn you don't hire.
Potential negatives
* data - we all agree that data will be the catalyst. A so so outcome can still provide hope with so many variations on the cards, but the expectations are so high now, the SP would be crushed on avg news, even if only short term.
* Funding / CR / market confidence. The last CR showed the regular punters seemed to have had enough of stumping up with less than great outcomes. The tide may have turned a little, but was a big shortfall last time.
* Consolidation. Ive been a little smart on this one, but given the popular belief that the sky was falling post consolidation, the rise and hold of the SP seems to have put pay to this?
Like any business case, keen to rip it apart and find the potential issues I didn't initially see.
- Forums
- ASX - By Stock
- What could go wrong?
IMM
immutep limited
Add to My Watchlist
0.00%
!
24.0¢

Apologies for the extended dribble, I'll put it down to the half...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $350.4M |
Open | High | Low | Value | Volume |
24.0¢ | 25.5¢ | 24.0¢ | $740K | 3.015M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 597321 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 123304 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 573295 | 0.240 |
4 | 336102 | 0.235 |
9 | 304672 | 0.230 |
11 | 387839 | 0.225 |
20 | 1168265 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 123304 | 5 |
0.255 | 307829 | 7 |
0.260 | 341203 | 8 |
0.265 | 486184 | 4 |
0.270 | 53000 | 3 |
Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online